School of Medicine


Showing 11-14 of 14 Results

  • Joshua Mooney

    Joshua Mooney

    Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    Current Research and Scholarly InterestsOutcomes and Health Services Research in Advanced Lung Disease & Lung Transplant

  • Andrew Reese Moore

    Andrew Reese Moore

    Instructor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    Current Research and Scholarly InterestsI am co-mentored by Dr. Angela Rogers and Dr. Purvesh Khatri. My research focuses on leveraging machine learning on multi-omic data to evaluate the immune response in critical illness. It is striking that despite many years of studying infections, we still treat patients with severe infections the same as we did 30 years ago, with antimicrobials, fluids, and supportive care. The goal of my research is to bring the ideals of precision medicine to critical care. In particular, I am working to better quantify how the immune system responds to infections with the goal of being able to "read" the immune system and treat patients with the medications they need to successfully recover.

  • Carson T. Moss

    Carson T. Moss

    Affiliate, Department Funds
    Fellow in Medicine - Med/Pulmonary, Allergy & Critical Care Medicine

    BioDr. Carson T. Moss is a Pulmonary and Critical Care Medicine fellow at Stanford University, where he completed his Internal Medicine residency training. His clinical and research program centers on pulmonary complications in immunocompromised patients, with a primary focus on bronchiolitis obliterans syndrome (BOS), a rare and often irreversible obstructive airway disease arising as a manifestation of chronic graft-versus-host disease (cGVHD) following allogeneic hematopoietic cell transplantation (HCT). To characterize disease onset and progression, his investigative work applies quantitative CT imaging and longitudinal pulmonary function metrics as non-invasive diagnostic and monitoring tools, with parallel interest in respiratory infectious complications in this population. Central to this work is an emerging focus on bronchiectasis, particularly as a co-occurring complication of BOS after HCT.

    Dr. Moss has contributed to multicenter clinical trials including STOP-BOS, ATHOS-III, and PETAL-ROSE, and his original research has been published in Blood Advances and Transplantation and Cellular Therapy, with findings presented at the American Thoracic Society International Conference. He conducts clinical and translational research within the Hsu Lab, in collaboration with Dr. Joe Hsu. Dr. Moss maintains an active commitment to medical education, with leadership experience in organized medicine and mentorship of trainees across academic medicine.